Phase II Artesunate Study in Severe Malaria

NCT00522132 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Artesunate

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]